Actionable news
0
All posts from Actionable news
Actionable news in ACOR: Acorda Therapeutics, Inc.,

Acorda Therapeutics Inc.

Average Recommendation: Overweight Average Target Price: 41.80
Number of Ratings: 9 Current Quarters Estimate: -0.16
FY Report Date: 12 / 2016 Current Year's Estimate: 0.05
Last Quarter's Earnings: 0.21 Median PE on CY...

More